Literature DB >> 28722192

Roles of Fas/FasL-mediated apoptosis and inhibin B in the testicular dysfunction of rats with left-side varicocele.

J Zhang1, P P Jin2, M Gong1, J H Guo3, K Fang1, Q T Yi1, R J Zhu1.   

Abstract

We investigated the role of the Fas/FasL signalling pathway and inhibin B expression in rats with an experimentally induced left-side varicocele. Forty-five Sprague Dawley (SD) male rats were randomly divided into three groups in average: control group, sham group and experimental group. The expression of inhibin B in the rat left testis was analysed at the mRNA and protein levels by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting respectively. The expressions of Fas, FasL and caspase-3 in the left testis were measured by RT-PCR and immunofluorescence. The apoptosis index (AI) was measured by terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL). Both the mRNA and protein of inhibin B were significantly reduced in the experimental group compared with that in the control group or the sham group. The expression of Fas, FasL and caspase-3 in the experimental group was significantly increased compared to that in the control group or the sham group. The concentration of serum inhibin B was also inversely related to circulating FSH concentrations and positively correlated with sperm count. It is concluded that Fas/FasL system may play an important role in apoptosis of rats with experimental varicocele and inhibin B could reflect spermatogenesis function.
© 2017 Blackwell Verlag GmbH.

Entities:  

Keywords:  Fas/FasL; apoptosis; inhibin B; testicular dysfunction; varicocele

Mesh:

Substances:

Year:  2017        PMID: 28722192     DOI: 10.1111/and.12850

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  1 in total

1.  Comparison of the clinical characteristics of patients with varicocele according to the presence or absence of scrotal pain.

Authors:  Seung Ryong Baek; Hyun Jun Park; Nam Cheol Park
Journal:  Andrologia       Date:  2018-10-25       Impact factor: 2.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.